108 results on '"Tono N"'
Search Results
2. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma
3. Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis
4. Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes
5. Improved detection of HCC by co-determination of IgM anti-AFP antibodies and AFP-IgM immune complexes
6. Experimental validation of specificity of the SCCA-IgM assay in patients with cirrhosis
7. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients
8. SerpinB3 drives molecular signatures of worse prognosis and is associated with tumor recurrence in hepatocellular carcinoma
9. LEADING ROLE OF SERPINB3 IN MOLECULAR SIGNATURES OF WORSE PROGNOSIS IN HEPATOCELLULAR CARCINOMA
10. RUOLO DI SERPINB3 NELLA PROGRESSIONE DELLA MALATTIA EPATICA
11. RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA
12. IMPROVED DIAGNOSTIC ACCURACY FOR HCC USING A COMBINATION OF IgM-LINKED BIOMARKERS
13. OSTEOPONTIN-IGM AS A MARKER OFR THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA
14. SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE OF VIRAL ETIOLOGY
15. SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE
16. COMBINATION OF BIOMARKERS-IGM BYLOGISTIC REGRESSION IMPROVES DIAGNOSTIC ACCURACY IN HEPATOCELLULAR CARCINOMA
17. ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA
18. ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA
19. SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE
20. SERUM SQUAMOUS CELL CARCINOMA ANTIGEN-IgM (SCCA-IgM) IMMUNOCOMPLEX: A NEW BIOMARKER FOR CANCER OF THE ESOPHAGUS
21. DETERMINAZIONE DELL’IMMUNOCOMPLESSO VEGF-IgM NELL’ EPATOCARCINOMA
22. SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA)-IgM COMPLEX: SCCA1-IgM and SCCA2-IgM COMPARED TO TOTAL SCCA-IgM FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA
23. VASCULAR ENDOTELIAL GROWTH FACTOR (VEGF)- IgM COMPLEX FOR THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA
24. Monitoring SCCA-IgM complex predicts hcc development in cirrhotic patients
25. Monitoring SCCA-IgM complex predicts liver disease progression in patients with chronic hepatitis and cirrhosis
26. COMPORTAMENTO DI SCCA-IgM NEL SIERO DI BAMBINI HBeAg POSITIVI SEGUITI NEL TEMPO
27. Activation of pivotal cell cycle proteins and inhibition of apoptosis by SCCA1 in HepG2 cells
28. P569 SCCA-IgM IS PREDICTIVE OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN PATIENTS WITH HCV CIRRHOSIS. A PROSPECTIVE STUDY
29. SERPINS AND LIVER DISEASE
30. SCCA-IgM is predictive of hepatocellular carcinoma development in patients with HCV cirrhosis—A prospective study
31. T-54 SerpinB3 drives molecular signatures of worse prognosis and is associated with tumor recurrence in hepatocellular carcinoma
32. T-38 Leading role of SerpinB3 in molecular signatures of worse prognosis in hepatocellular carcinoma
33. 262 SERPINB3 IS ASSOCIATED TO LONGER SURVIVAL IN MALE TRANSGENIC MICE
34. 956 IMPROVED DETECTION OF HCC BY CO-DETERMINATION OF IGM ANTI-AFP ANTIBODIES AND AFP-IGM IMMUNE COMPLEXES
35. T-45 Improved diagnostic accuracy for HCC using a combination of IgM-linked biomarkers
36. Combining SCCA-IgM and AFP-IgM levels increases accuracy of hepatocellular carcinoma detection
37. Osteopontin-IgM in the diagnosis of HCC
38. SCCA-IgM usefulness to monitor patients with cirrhosis is not affected by interfering IgM's
39. 300 SERPINB3 AND TGF-β1 CORRELATION IN CHRONIC LIVER DISEASE
40. 856 HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS
41. SERPINB3 and TGF-β1 in chronic liver disease
42. Hepatocellular carcinoma induces specific IgM-biomarkers immune complexes
43. HFE, TGF-BETA1 and squamous cell carcinoma antigen-1 polymorphisms and liver disease stage in chronic HCV infection
44. P.381 Monitoring SCCA-IgM complex predicts liver disease progression in patients with chronic hepatitis and cirrhosis
45. Surface expression of squamous cell carcinoma antigen (SCCA) can be increased by the preS1(21–47) sequence of hepatitis B virus
46. 271 Monitoring SCCA-IGM complex predicts HCC development in cirrhotic patients
47. CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE
48. IL RUOLO DELL’IMMUNOCOMPLESSO OSETOPONTINA-IgM NELLA DIAGNOSI DELL’EPATOCARCINOMA
49. [An adult case of acute pericarditis and glomerulonephritis associated with human parvovirus B19 infection].
50. SERPINB3 is associated with longer survival in transgenic mice.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.